本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

維羅納製藥

90.08
-0.4000-0.44%
盤後90.900.8340+0.93%19:45 EDT
成交量:96.25萬
成交額:8,766.45萬
市值:76.69億
市盈率:-44.64
高:93.39
開:89.42
低:89.10
收:90.48
資料載入中...
2024/11/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/15

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/15

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/15

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/04

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/04

重要事件披露

Form 8-K - Current report
2024/10/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/28

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/08

重要事件披露

Form 8-K - Current report
2024/07/29

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors